Article
Molecular pathology of non-small cell carcinoma.
Histopathology - 1 Jan 2024
Yatabe Yasushi
Abstract excerpt
Currently, lung cancer is treated by the highest number of therapeutic options and the benefits are based on multiple large-scale sequencing studies, translational research and new drug development, which has promoted our understanding of the molecular pathology of lung cancer. According to the driver alterations, different characteristics have been revealed, such as differences in ethnic prevalence, median age...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
